Management Discussion & Analysis

MD&A Q4 2024 (Jul 31, 2024)
MD&A Q3 2024 (Apr 30, 2024)
MD&A Q2 2024 (Jan 31, 2024)
MD&A Q1 2024 (Oct 31, 2023)

MD&A Q4 2023 (Jul 31, 2023)
MD&A Q3 2023 (Apr 30, 2023)
MD&A Q2 2023 (Jan 31, 2023)
MD&A Q1 2023 (Oct 31, 2022)

MD&A Q4 2022 (Jul 31, 2022)
MD&A Q3 2022 (Apr 30, 2022)
MD&A Q2 2022 (Jan 31, 2022)
MD&A Q1 2022 (Oct 31, 2021)

MD&A Q4 2021 (Jul 31, 2021)
MD&A Q3 2021 (Apr 30, 2021)
MD&A Q2 2021 (Jan 31, 2021)
MD&A Q1 2021 (Oct 31, 2020)

MD&A Q4 2020 (Jul 31, 2020)
MD&A Q3 2020 (Apr 30, 2020)
MD&A Q2 2020 (Jan 31, 2020)
MD&A Q1 2020 (Oct 31, 2019)

Note: Angkor did not meet the threshold for filing an ESTMA report for 2018-19

MD&A Q4 2019 (Jul 31, 2019)
MD&A Q3 2019 (Apr 30, 2019)
MD&A Q2 2019 (Jan 31, 2019)
MD&A Q1 2019 (Oct 31, 2018)

Note: Angkor did not meet the threshold for filing an ESTMA report for 2017-18

MD&A Q4 2018 (Jul 31, 2018)
MD&A Q3 2018 (Apr 30, 2018)
MD&A Q2 2018 (Jan 31, 2018)
MD&A Q1 2018 (Oct 31, 2017)
2016-17 ESTMA Report (Company ID Number E832133)

MD&A Q4 2017 (Jul 31, 2017)
MD&A Q3 2017(Apr 30, 2017)
MD&A Q2 2017 (Jan 31, 2017)
MD&A Q1 2017 (Oct 31, 2016)

MD&A Q4 2016 (Jul 31, 2016)
MD&A Q3 2016 (Apr 30, 2016)
MD&A Q2 2016 (Jan 31, 2016)
MD&A Q1 2016 (Oct 31, 2015)

MD&A Q4 2015 (Jul 31, 2015)
MD&A Q3 2015 (Apr 30, 2015)
MD&A Q2 2015 (Jan 31, 2015)
MD&A Q1 2015 (Oct 31, 2014)

MD&A Q4 2014 (Jul 31, 2014)
MD&A Q3 2014 (Apr30, 2014)
MD&A Q2 2014 (Jan 31, 2014)
MD&A Q1 2014 (Oct 31, 2013)

MD&A July 31, 2013
MD&A April 30, 2013
MD&A January 31, 2013

MD&A October 31, 2012
MD&A July 31, 2012
MD&A April 30, 2012
MD&A January 31, 2012

MD&A October 31, 2011
MD&A September 30, 2011
MD&A June 30, 2011
MD&A March 31, 2011

MD&A December 31, 2010